Takeo Mori

3.5k total citations
67 papers, 2.2k citations indexed

About

Takeo Mori is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Takeo Mori has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 18 papers in Surgery and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Takeo Mori's work include Genetic factors in colorectal cancer (14 papers), Colorectal Cancer Surgical Treatments (12 papers) and Colorectal Cancer Treatments and Studies (12 papers). Takeo Mori is often cited by papers focused on Genetic factors in colorectal cancer (14 papers), Colorectal Cancer Surgical Treatments (12 papers) and Colorectal Cancer Treatments and Studies (12 papers). Takeo Mori collaborates with scholars based in Japan, United States and Kazakhstan. Takeo Mori's co-authors include Tomoyuki Kato, Hidetaka Mochizuki, Kenichi Sugihara, Shingo Kameoka, Hirotoshi Kobayashi, Michiko Miyaki, Kazuo Shirouzu, Tatsuro Yamaguchi, Takeru Iijima and Keiichi Takahashi and has published in prestigious journals such as Applied Physics Letters, Oncogene and Annals of Surgery.

In The Last Decade

Takeo Mori

65 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takeo Mori Japan	25	1.2k	770	746	373	355	67	2.2k
Kees Smid Netherlands	29	1.7k 1.4×	316 0.4×	1.5k 2.0×	606 1.6×	350 1.0×	90	3.1k
C.J. van Groeningen Netherlands	28	1.4k 1.1×	279 0.4×	983 1.3×	483 1.3×	290 0.8×	51	2.4k
Teiji Takechi Japan	26	1.3k 1.1×	266 0.3×	760 1.0×	644 1.7×	236 0.7×	63	1.9k
Xiangdong Cheng China	28	1.0k 0.8×	416 0.5×	1.8k 2.4×	572 1.5×	278 0.8×	133	3.1k
Stephan Ruetz Switzerland	23	2.0k 1.6×	416 0.5×	1.7k 2.3×	340 0.9×	119 0.3×	36	3.5k
David Edler Sweden	19	835 0.7×	244 0.3×	527 0.7×	233 0.6×	403 1.1×	38	1.4k
Robert D. Ladner United States	32	1.6k 1.3×	233 0.3×	1.9k 2.6×	375 1.0×	339 1.0×	51	3.3k
Minnie Y.Y. Go Hong Kong	31	362 0.3×	651 0.8×	1.2k 1.6×	327 0.9×	179 0.5×	41	2.6k
Hong‐Yang Wang China	20	832 0.7×	417 0.5×	1.3k 1.7×	154 0.4×	220 0.6×	30	3.0k
Takefumi Ohga Japan	25	791 0.6×	570 0.7×	1.4k 1.8×	594 1.6×	183 0.5×	67	2.4k

Countries citing papers authored by Takeo Mori

Since Specialization

Citations

This map shows the geographic impact of Takeo Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Mori more than expected).

Fields of papers citing papers by Takeo Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Mori. The network helps show where Takeo Mori may publish in the future.

Co-authorship network of co-authors of Takeo Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Mori. A scholar is included among the top collaborators of Takeo Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Mori. Takeo Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mori, Takeo, Masayuki Ohue, Yasumasa Takii, et al.. (2012). Factors predicting the response to oral fluoropyrimidine drugs: A phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study). Oncology Reports. 29(2). 437–444. 10 indexed citations

Kobayashi, Hirotoshi, Hidetaka Mochizuki, Tomoyuki Kato, et al.. (2011). Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study. International Journal of Colorectal Disease. 26(7). 891–896. 28 indexed citations

Mori, Takeo. (2010). A Comparison of the New (Planned) TNM Classification and Japanese General Rule for Staging Colorectal Cancer. Cancer Investigation. 28(4). 387–392. 19 indexed citations

Yamaguchi, Tatsuro, et al.. (2010). Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases. Cancer Chemotherapy and Pharmacology. 67(3). 629–635. 7 indexed citations

Kawakami, Masayo, Tatsuro Yamaguchi, Keiichi Takahashi, et al.. (2010). Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer. Surgery Today. 40(3). 245–250. 11 indexed citations

Miyaki, Michiko, Tatsuro Yamaguchi, Takeru Iijima, et al.. (2008). Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: Variations with phenotype. International Journal of Cancer. 122(11). 2491–2497. 28 indexed citations

Yamaguchi, Tatsuro, Hiroko Bando, Takeo Mori, et al.. (2007). Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis. Cancer Science. 98(3). 405–410. 47 indexed citations

Sugihara, Kenichi, Hirotoshi Kobayashi, Tomoyuki Kato, et al.. (2006). Indication and Benefit of Pelvic Sidewall Dissection for Rectal Cancer. Diseases of the Colon & Rectum. 49(11). 1663–1672. 313 indexed citations

Miyaki, Michiko, Tatsuro Yamaguchi, Takeru Iijima, Nobuaki Funata, & Takeo Mori. (2006). Difference in the Role of Loss of Heterozygosity at 10p15 (KLF6 Locus) in Colorectal Carcinogenesis between Sporadic and Familial Adenomatous Polyposis and Hereditary Nonpolyposis Colorectal Cancer Patients. Oncology. 71(1-2). 131–135. 17 indexed citations

10.

Miyaki, Michiko, Takeru Iijima, Tatsuro Yamaguchi, et al.. (2004). Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 548(1-2). 19–25. 4 indexed citations

11.

Miyaki, Michiko, Takeru Iijima, Tatsuro Yamaguchi, et al.. (2004). Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer. Cancer Letters. 211(1). 105–109. 21 indexed citations

12.

Miyanari, Nobutomo, Takeo Mori, Keiichi Takahashi, & Masamichi Yasuno. (2002). Evaluation of Aggressively Treated Patients With Unresectable Multiple Liver Metastases From Colorectal Cancer. Diseases of the Colon & Rectum. 45(11). 1503–1509. 20 indexed citations

13.

Miyaki, Michiko, Takeru Iijima, Masamichi Yasuno, et al.. (2002). High incidence of protein-truncating mutations of the p53 gene in liver metastases of colorectal carcinomas. Oncogene. 21(43). 6689–6693. 17 indexed citations

14.

Shimazu, Kenzo, Nobuaki Funata, Yutaka Yamamoto, & Takeo Mori. (2001). Primary osteosarcoma arising in the colon. Diseases of the Colon & Rectum. 44(9). 1367–1370. 14 indexed citations

15.

Miyaki, Michiko, Takeru Iijima, Kiyotaka Shiba, et al.. (2001). Alterations of repeated sequences in 5′ upstream and coding regions in colorectal tumors from patients with hereditary nonpolyposis colorectal cancer and Turcot syndrome. Oncogene. 20(37). 5215–5218. 21 indexed citations

16.

Yasuno, Masamichi, Takeo Mori, & Keiichi Takahashi. (1997). Our New Propose for the Length of the Bowel to be Resected in the Colorectal Cancer Operation. The Study of the Bowel Habits after the Right Hemicolectomy and the Low Anterior Resection.. The Japanese Journal of Gastroenterological Surgery. 30(10). 2112–2116. 2 indexed citations

17.

Hirabayashi, Kazuhiro, Susumu Iwata, Hiroatsu Matsumoto, et al.. (1991). Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1(HIV-1) and herpes simplex virus type 1(HSV-1) in vitro.. Chemical and Pharmaceutical Bulletin. 39(1). 112–115. 81 indexed citations

18.

Inoue, Hideo, Takeo Mori, Shoji Shibata, & Yasuko Koshihara. (1989). Modulation by glycyrrhetinic acid derivatives of TPA‐induced mouse ear oedema. British Journal of Pharmacology. 96(1). 204–210. 55 indexed citations

19.

Kitamura, Masatsugu, et al.. (1988). Nonocclusive mesenteric infarction: Report of 6 cases.. The Japanese Journal of Gastroenterological Surgery. 21(4). 1138–1141.

20.

Inoue, Hideo, Takeo Mori, & Yasuko Koshihara. (1988). Sulfidopeptide-leukotrienes are major mediators of arachinodic acid-induced mouse ear edema. Prostaglandins. 36(5). 731–739. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact